scispace - formally typeset
S

Sarah N. Hilmer

Researcher at Royal North Shore Hospital

Publications -  357
Citations -  15058

Sarah N. Hilmer is an academic researcher from Royal North Shore Hospital. The author has contributed to research in topics: Deprescribing & Polypharmacy. The author has an hindex of 56, co-authored 315 publications receiving 12170 citations. Previous affiliations of Sarah N. Hilmer include National Health and Medical Research Council & Concord Repatriation General Hospital.

Papers
More filters
Journal ArticleDOI

Reducing Inappropriate Polypharmacy: The Process of Deprescribing

TL;DR: A deprescribing protocol is proposed comprising 5 steps: ascertain all drugs the patient is currently taking and the reasons for each one, and prioritize drugs for discontinuation that have the lowest benefit-harm ratio and lowest likelihood of adverse withdrawal reactions or disease rebound syndromes.
Journal ArticleDOI

Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency.

TL;DR: Calorie restriction can induce a peroxisome proliferation-activated receptor coactivator 1 alpha-dependent increase in mitochondria capable of efficient and balanced bioenergetics to reduce oxidative stress and attenuate age-dependent endogenous oxidative damage.
Journal ArticleDOI

A Drug Burden Index to Define the Functional Burden of Medications in Older People

TL;DR: The drug burden index demonstrates that anticholinergic and sedative drug exposure is associated with poorer function in community-dwelling older people and provides a useful evidence-based tool for assessing the functional effect of exposure to medications in this population.
Journal ArticleDOI

A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice.

TL;DR: Findings show that there is lack of consensus on the definition of deprescribing and the following definition is proposed: 'Depresc prescribing is the process of withdrawal of an inappropriate medication, supervised by a health care professional with the goal of managing polypharmacy and improving outcomes'.